List of Tables
Table 1. Global Antibacterial and Antiviral Clothing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Antibacterial and Antiviral Clothing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Antibacterial and Antiviral Clothing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Antibacterial and Antiviral Clothing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Antibacterial and Antiviral Clothing Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Antibacterial and Antiviral Clothing Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Antibacterial and Antiviral Clothing Sales by Region (2020-2025) & (Units)
Table 8. Global Antibacterial and Antiviral Clothing Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Antibacterial and Antiviral Clothing Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global Antibacterial and Antiviral Clothing Sales Share by Manufacturers (2020-2025)
Table 12. Global Antibacterial and Antiviral Clothing Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Antibacterial and Antiviral Clothing Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Antibacterial and Antiviral Clothing by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibacterial and Antiviral Clothing as of 2024)
Table 16. Global Antibacterial and Antiviral Clothing Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Antibacterial and Antiviral Clothing Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Antibacterial and Antiviral Clothing Manufacturing Base and Headquarters
Table 19. Global Antibacterial and Antiviral Clothing Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Antibacterial and Antiviral Clothing Sales by Type (2020-2025) & (Units)
Table 23. Global Antibacterial and Antiviral Clothing Sales by Type (2026-2031) & (Units)
Table 24. Global Antibacterial and Antiviral Clothing Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Antibacterial and Antiviral Clothing Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Antibacterial and Antiviral Clothing ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Antibacterial and Antiviral Clothing Sales by Application (2020-2025) & (Units)
Table 29. Global Antibacterial and Antiviral Clothing Sales by Application (2026-2031) & (Units)
Table 30. Antibacterial and Antiviral Clothing High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Antibacterial and Antiviral Clothing Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Antibacterial and Antiviral Clothing Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Antibacterial and Antiviral Clothing ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Antibacterial and Antiviral Clothing Growth Accelerators and Market Barriers
Table 37. North America Antibacterial and Antiviral Clothing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Antibacterial and Antiviral Clothing Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Antibacterial and Antiviral Clothing Growth Accelerators and Market Barriers
Table 40. Europe Antibacterial and Antiviral Clothing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Antibacterial and Antiviral Clothing Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Antibacterial and Antiviral Clothing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Antibacterial and Antiviral Clothing Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Antibacterial and Antiviral Clothing Growth Accelerators and Market Barriers
Table 45. Southeast Asia Antibacterial and Antiviral Clothing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Antibacterial and Antiviral Clothing Investment Opportunities and Key Challenges
Table 47. Central and South America Antibacterial and Antiviral Clothing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Antibacterial and Antiviral Clothing Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Antibacterial and Antiviral Clothing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Annil Corporation Information
Table 51. Annil Description and Major Businesses
Table 52. Annil Product Models, Descriptions and Specifications
Table 53. Annil Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Annil Sales Value Proportion by Product in 2024
Table 55. Annil Sales Value Proportion by Application in 2024
Table 56. Annil Sales Value Proportion by Geographic Area in 2024
Table 57. Annil Antibacterial and Antiviral Clothing SWOT Analysis
Table 58. Annil Recent Developments
Table 59. Hongdou Group Corporation Information
Table 60. Hongdou Group Description and Major Businesses
Table 61. Hongdou Group Product Models, Descriptions and Specifications
Table 62. Hongdou Group Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Hongdou Group Sales Value Proportion by Product in 2024
Table 64. Hongdou Group Sales Value Proportion by Application in 2024
Table 65. Hongdou Group Sales Value Proportion by Geographic Area in 2024
Table 66. Hongdou Group Antibacterial and Antiviral Clothing SWOT Analysis
Table 67. Hongdou Group Recent Developments
Table 68. Semir Group Corporation Information
Table 69. Semir Group Description and Major Businesses
Table 70. Semir Group Product Models, Descriptions and Specifications
Table 71. Semir Group Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Semir Group Sales Value Proportion by Product in 2024
Table 73. Semir Group Sales Value Proportion by Application in 2024
Table 74. Semir Group Sales Value Proportion by Geographic Area in 2024
Table 75. Semir Group Antibacterial and Antiviral Clothing SWOT Analysis
Table 76. Semir Group Recent Developments
Table 77. Xin Hee Corporation Information
Table 78. Xin Hee Description and Major Businesses
Table 79. Xin Hee Product Models, Descriptions and Specifications
Table 80. Xin Hee Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Xin Hee Sales Value Proportion by Product in 2024
Table 82. Xin Hee Sales Value Proportion by Application in 2024
Table 83. Xin Hee Sales Value Proportion by Geographic Area in 2024
Table 84. Xin Hee Antibacterial and Antiviral Clothing SWOT Analysis
Table 85. Xin Hee Recent Developments
Table 86. Bosideng Corporation Information
Table 87. Bosideng Description and Major Businesses
Table 88. Bosideng Product Models, Descriptions and Specifications
Table 89. Bosideng Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Bosideng Sales Value Proportion by Product in 2024
Table 91. Bosideng Sales Value Proportion by Application in 2024
Table 92. Bosideng Sales Value Proportion by Geographic Area in 2024
Table 93. Bosideng Antibacterial and Antiviral Clothing SWOT Analysis
Table 94. Bosideng Recent Developments
Table 95. Key Raw Materials Distribution
Table 96. Raw Materials Key Suppliers
Table 97. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 98. Milestones in Production Technology Evolution
Table 99. Distributors List
Table 100. Market Trends and Market Evolution
Table 101. Market Drivers and Opportunities
Table 102. Market Challenges, Risks, and Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibacterial and Antiviral Clothing Product Picture
Figure 2. Global Antibacterial and Antiviral Clothing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Adult Clothing Product Picture
Figure 4. Children's Clothing Product Picture
Figure 5. Global Antibacterial and Antiviral Clothing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. On-Line
Figure 7. Off-Line
Figure 8. Antibacterial and Antiviral Clothing Report Years Considered
Figure 9. Global Antibacterial and Antiviral Clothing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
Figure 11. Global Antibacterial and Antiviral Clothing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Antibacterial and Antiviral Clothing Revenue Market Share by Region (2020-2031)
Figure 13. Global Antibacterial and Antiviral Clothing Sales (2020-2031) & (Units)
Figure 14. Global Antibacterial and Antiviral Clothing Sales (CAGR) by Region (2020-2031) (Units)
Figure 15. Global Antibacterial and Antiviral Clothing Sales Market Share by Region (2020-2031)
Figure 16. Top 5 and Top 10 Manufacturers Antibacterial and Antiviral Clothing Sales Volume Market Share in 2024
Figure 17. Global Antibacterial and Antiviral Clothing Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Adult Clothing Revenue Market Share by Manufacturer in 2024
Figure 20. Children's Clothing Revenue Market Share by Manufacturer in 2024
Figure 21. Global Antibacterial and Antiviral Clothing Sales Market Share by Type (2020-2031)
Figure 22. Global Antibacterial and Antiviral Clothing Revenue Market Share by Type (2020-2031)
Figure 23. Global Antibacterial and Antiviral Clothing Sales Market Share by Application (2020-2031)
Figure 24. Global Antibacterial and Antiviral Clothing Revenue Market Share by Application (2020-2031)
Figure 25. North America Antibacterial and Antiviral Clothing Sales YoY (2020-2031) & (Units)
Figure 26. North America Antibacterial and Antiviral Clothing Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Manufacturers Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) in 2024
Figure 28. North America Antibacterial and Antiviral Clothing Sales Volume (Units) by Type (2020- 2031)
Figure 29. North America Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 30. North America Antibacterial and Antiviral Clothing Sales Volume (Units) by Application (2020-2031)
Figure 31. North America Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Antibacterial and Antiviral Clothing Sales YoY (2020-2031) & (Units)
Figure 36. Europe Antibacterial and Antiviral Clothing Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Europe Top 5 Manufacturers Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) in 2024
Figure 38. Europe Antibacterial and Antiviral Clothing Sales Volume (Units) by Type (2020-2031)
Figure 39. Europe Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Type (2020-2031)
Figure 40. Europe Antibacterial and Antiviral Clothing Sales Volume (Units) by Application (2020-2031)
Figure 41. Europe Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. Germany Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
Figure 43. France Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
Figure 44. U.K. Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
Figure 45. Italy Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
Figure 46. Russia Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
Figure 47. Asia-Pacific Antibacterial and Antiviral Clothing Sales YoY (2020-2031) & (Units)
Figure 48. Asia-Pacific Antibacterial and Antiviral Clothing Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Top 8 Manufacturers Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) in 2024
Figure 50. Asia-Pacific Antibacterial and Antiviral Clothing Sales Volume (Units) by Type (2020- 2031)
Figure 51. Asia-Pacific Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 52. Asia-Pacific Antibacterial and Antiviral Clothing Sales Volume (Units) by Application (2020-2031)
Figure 53. Asia-Pacific Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Indonesia Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
Figure 55. Japan Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
Figure 56. South Korea Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
Figure 57. China Taiwan Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
Figure 58. India Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
Figure 59. Central and South America Antibacterial and Antiviral Clothing Sales YoY (2020-2031) & (Units)
Figure 60. Central and South America Antibacterial and Antiviral Clothing Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Central and South America Top 5 Manufacturers Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) in 2024
Figure 62. Central and South America Antibacterial and Antiviral Clothing Sales Volume (Units) by Type (2021-2031)
Figure 63. Central and South America Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Type (2020-2031)
Figure 64. Central and South America Antibacterial and Antiviral Clothing Sales Volume (Units) by Application (2020-2031)
Figure 65. Central and South America Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Brazil Antibacterial and Antiviral Clothing Revenue (2020-2025) & (US$ Million)
Figure 67. Argentina Antibacterial and Antiviral Clothing Revenue (2020-2025) & (US$ Million)
Figure 68. Middle East, and Africa Antibacterial and Antiviral Clothing Sales YoY (2020-2031) & (Units)
Figure 69. Middle East and Africa Antibacterial and Antiviral Clothing Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Middle East and Africa Top 5 Manufacturers Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) in 2024
Figure 71. Middle East and Africa Antibacterial and Antiviral Clothing Sales Volume (Units) by Type (2021-2031)
Figure 72. South America Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Type (2020-2031)
Figure 73. Middle East and Africa Antibacterial and Antiviral Clothing Sales Volume (Units) by Application (2020-2031)
Figure 74. Middle East and Africa Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Application (2020-2031)
Figure 75. GCC Countries Antibacterial and Antiviral Clothing Revenue (2020-2025) & (US$ Million)
Figure 76. Turkey Antibacterial and Antiviral Clothing Revenue (2020-2025) & (US$ Million)
Figure 77. Egypt Antibacterial and Antiviral Clothing Revenue (2020-2025) & (US$ Million)
Figure 78. South Africa Antibacterial and Antiviral Clothing Revenue (2020-2025) & (US$ Million)
Figure 79. Antibacterial and Antiviral Clothing Industry Chain Mapping
Figure 80. Regional Antibacterial and Antiviral Clothing Manufacturing Base Distribution (%)
Figure 81. Global Antibacterial and Antiviral Clothing Production Market Share by Region (2020-2031)
Figure 82. Antibacterial and Antiviral Clothing Production Process
Figure 83. Regional Antibacterial and Antiviral Clothing Production Cost Structure
Figure 84. Channels of Distribution (Direct Vs Distribution)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed